Form 8-K - Current report:
SEC Accession No. 0001193125-25-278804
Filing Date
2025-11-13
Accepted
2025-11-13 07:00:39
Documents
42
Period of Report
2025-11-13
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aldx-20251113.htm   iXBRL 8-K 72402
2 EX-99.1 aldx-ex99_1.htm EX-99.1 33230
3 EX-99.2 aldx-ex99_2.htm EX-99.2 22541
4 GRAPHIC aldx-ex99_1s1.jpg GRAPHIC 242002
5 GRAPHIC aldx-ex99_1s2.jpg GRAPHIC 975494
6 GRAPHIC aldx-ex99_1s3.jpg GRAPHIC 455924
7 GRAPHIC aldx-ex99_1s4.jpg GRAPHIC 192235
8 GRAPHIC aldx-ex99_1s5.jpg GRAPHIC 386791
9 GRAPHIC aldx-ex99_1s6.jpg GRAPHIC 309690
10 GRAPHIC aldx-ex99_1s7.jpg GRAPHIC 236490
11 GRAPHIC aldx-ex99_1s8.jpg GRAPHIC 417870
12 GRAPHIC aldx-ex99_1s9.jpg GRAPHIC 320276
13 GRAPHIC aldx-ex99_1s10.jpg GRAPHIC 361430
14 GRAPHIC aldx-ex99_1s11.jpg GRAPHIC 291637
15 GRAPHIC aldx-ex99_1s12.jpg GRAPHIC 194682
16 GRAPHIC aldx-ex99_1s13.jpg GRAPHIC 355289
17 GRAPHIC aldx-ex99_1s14.jpg GRAPHIC 335209
18 GRAPHIC aldx-ex99_1s15.jpg GRAPHIC 425540
19 GRAPHIC aldx-ex99_1s16.jpg GRAPHIC 364373
20 GRAPHIC aldx-ex99_1s17.jpg GRAPHIC 272167
21 GRAPHIC aldx-ex99_1s18.jpg GRAPHIC 329109
22 GRAPHIC aldx-ex99_1s19.jpg GRAPHIC 313390
23 GRAPHIC aldx-ex99_1s20.jpg GRAPHIC 316515
24 GRAPHIC aldx-ex99_1s21.jpg GRAPHIC 357823
25 GRAPHIC aldx-ex99_1s22.jpg GRAPHIC 454641
26 GRAPHIC aldx-ex99_1s23.jpg GRAPHIC 408898
27 GRAPHIC aldx-ex99_1s24.jpg GRAPHIC 192687
28 GRAPHIC aldx-ex99_1s25.jpg GRAPHIC 393029
29 GRAPHIC aldx-ex99_1s26.jpg GRAPHIC 363892
30 GRAPHIC aldx-ex99_1s27.jpg GRAPHIC 475088
31 GRAPHIC aldx-ex99_1s28.jpg GRAPHIC 449327
32 GRAPHIC aldx-ex99_1s29.jpg GRAPHIC 136684
33 GRAPHIC aldx-ex99_1s30.jpg GRAPHIC 321738
  Complete submission text file 0001193125-25-278804.txt   14927578

Data Files

Seq Description Document Type Size
34 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT aldx-20251113.xsd EX-101.SCH 30863
44 EXTRACTED XBRL INSTANCE DOCUMENT aldx-20251113_htm.xml XML 4712
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Filer) CIK: 0001341235 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36332 | Film No.: 251475328
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)